Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Qsymia (phentermine/topiramate) and Wegovy (semaglutide) are both medications used for weight loss in adults and children aged 12 and older. However, they have some important differences. Qsymia is a combination of a sympathomimetic and an antiepileptic, while Wegovy is a GLP-1 agonist. Qsymia is taken orally once a day, whereas Wegovy is injected under the skin once a week. Qsymia is a controlled substance because it contains phentermine, while Wegovy is not a controlled substance. Common side effects of Qsymia include dry mouth and constipation, while Wegovy often causes nausea and diarrhea. Qsymia can cause a fast heart beat, while Wegovy can increase the risk of some types of thyroid cancers. Both medications can cause problems with vision.
Qsymia (phentermine / topiramate ER)
Wegovy (semaglutide)
Qsymia (phentermine / topiramate ER)
Wegovy (semaglutide)
Summary of Qsymia vs. Wegovy
Summary for Sympathomimetic / Antiepileptic
Prescription only
Qsymia (phentermine / topiramate extended release) is a combination medication used to help with weight loss. It's approved for people over 12 who are considered obese and for some adults who are considered overweight. This medication is a tablet that you take once a day. You should also eat a balanced diet and exercise regularly for best results. Side effects include a "pins-and-needles" feeling, dry mouth, and constipation. You can only get this medication through the Qsymia REMS (Risk Evaluation and Mitigation Strategies) program because of the risk of birth defects if taken during pregnancy.
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It comes in prefilled pens you use to inject the medication under the skin once a week. Wegovy (semaglutide) also comes as tablets that are swallowed once a day. This medication is approved for weight loss in some people. It can help lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The pens are also approved for certain adults with a liver problem called metabolic dysfunction-associated steatohepatitis (MASH). The medication works best when taken with a lower-calorie diet and regular exercise. Side effects include nausea, diarrhea, and stomach pain.
Indications of Qsymia vs. Wegovy
Indications for
•Weight loss and long-term weight management, together with diet and exercise, for certain people: